產(chǎn)品展示
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1622
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1658
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1829
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1649
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1560
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1666
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1649
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1771

